Envestnet Asset Management Inc F Star Therapeutics, Inc. Transaction History

Envestnet Asset Management Inc

  • $281 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
SELL
$4.09 - $6.86 $5,460 - $9,158
-1,335 Reduced 10.76%
11,067 $69,000
Q3 2022

Nov 10, 2022
SELL
$5.41 - $6.74 $10,338 - $12,880
-1,911 Reduced 13.35%
12,402 $63,000
Q2 2022

Aug 03, 2022
BUY
$2.18 - $6.39 $1,632 - $4,786
749 Added 5.52%
14,313 $90,000
Q1 2022

May 04, 2022
BUY
$2.77 - $5.36 $37,572 - $72,703
13,564 New
13,564 $48,000

Others Institutions Holding FSTX

# of Institutions
3
Shares Held
44.7K
Call Options Held
0
Put Options Held
0
View Full List

About F-star Therapeutics, Inc.

FSTX Quotes by TradingView
  • Ticker FSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,584,700
  • Description
  • F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...
More about FSTX
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email